Lassina Barro

638 total citations
19 papers, 418 citations indexed

About

Lassina Barro is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Lassina Barro has authored 19 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Lassina Barro's work include Mesenchymal stem cell research (9 papers), Periodontal Regeneration and Treatments (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Lassina Barro is often cited by papers focused on Mesenchymal stem cell research (9 papers), Periodontal Regeneration and Treatments (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Lassina Barro collaborates with scholars based in Taiwan, Sweden and France. Lassina Barro's co-authors include Thierry Burnouf, Ouada Nebie, Jerard Seghatchian, Yu‐Wen Wu, Folke Knutson, Ming‐Fa Hsieh, Ming‐Li Chou, David Devos, Luc Buée and David Blum and has published in prestigious journals such as Brain, International Journal of Molecular Sciences and Journal of Materials Chemistry B.

In The Last Decade

Lassina Barro

19 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lassina Barro Taiwan 14 129 78 65 56 53 19 418
Marzia De Gironcoli Italy 16 71 0.6× 109 1.4× 21 0.3× 199 3.6× 77 1.5× 33 656
Rūta Aldonytė Lithuania 12 167 1.3× 86 1.1× 35 0.5× 36 0.6× 81 1.5× 27 626
A Werner United States 16 63 0.5× 63 0.8× 5 0.1× 63 1.1× 125 2.4× 40 664
Thuy T. P. Nguyen United States 14 233 1.8× 164 2.1× 29 0.4× 11 0.2× 117 2.2× 25 697
Zhidan Zhang China 14 107 0.8× 50 0.6× 18 0.3× 20 0.4× 130 2.5× 46 610
Shaban Alizadeh Iran 16 270 2.1× 131 1.7× 6 0.1× 271 4.8× 36 0.7× 91 812
Jae Joon Han South Korea 13 121 0.9× 23 0.3× 15 0.2× 27 0.5× 123 2.3× 48 683
Guixiang Sun China 14 159 1.2× 48 0.6× 4 0.1× 53 0.9× 80 1.5× 39 462
Yaqiu Sang United States 6 62 0.5× 29 0.4× 12 0.2× 184 3.3× 50 0.9× 16 437

Countries citing papers authored by Lassina Barro

Since Specialization
Citations

This map shows the geographic impact of Lassina Barro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lassina Barro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lassina Barro more than expected).

Fields of papers citing papers by Lassina Barro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lassina Barro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lassina Barro. The network helps show where Lassina Barro may publish in the future.

Co-authorship network of co-authors of Lassina Barro

This figure shows the co-authorship network connecting the top 25 collaborators of Lassina Barro. A scholar is included among the top collaborators of Lassina Barro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lassina Barro. Lassina Barro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Barro, Lassina, et al.. (2025). Sulforaphane from broccoli, an epigenetic modulator in cancer cells. Discover Oncology. 16(1). 1830–1830. 1 indexed citations
2.
Wu, Yu‐Wen, Liling Delila, Ouada Nebie, et al.. (2023). Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization. Platelets. 34(1). 2237134–2237134. 23 indexed citations
3.
Delila, Liling, Ouada Nebie, Lassina Barro, et al.. (2022). Neuroprotective activity of a virus‐safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models. Bioengineering & Translational Medicine. 8(1). e10360–e10360. 14 indexed citations
4.
Barro, Lassina, Liling Delila, Ouada Nebie, et al.. (2021). Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth medium supplemented with 10% human platelet lysate. Cytotherapy. 23(10). 902–907. 6 indexed citations
5.
Cheng, Chun‐Yuan, Lassina Barro, Shang‐Ting Tsai, et al.. (2021). Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection. International Journal of Molecular Sciences. 22(6). 3037–3037. 66 indexed citations
6.
Barro, Lassina, et al.. (2021). Cytoprotective Effect of Liposomal Puerarin on High Glucose-Induced Injury in Rat Mesangial Cells. Antioxidants. 10(8). 1177–1177. 14 indexed citations
7.
Nebie, Ouada, Kévin Carvalho, Lassina Barro, et al.. (2021). Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment. Brain. 144(10). 3142–3158. 36 indexed citations
8.
Barro, Lassina, Liling Delila, Ouada Nebie, et al.. (2021). Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth media supplemented with 10% human platelet lysate. Cytotherapy. 23(5). S176–S177. 1 indexed citations
9.
Nebie, Ouada, Lassina Barro, Yu‐Wen Wu, et al.. (2020). Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiationin vitro. Platelets. 32(2). 226–237. 22 indexed citations
10.
Barro, Lassina, Ouada Nebie, Ming Sheng Chen, et al.. (2020). Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells. Cytotherapy. 22(8). 458–472. 13 indexed citations
11.
Barro, Lassina, Pierre‐Alain Burnouf, Ming‐Li Chou, et al.. (2020). Human platelet lysates for human cell propagation. Platelets. 32(2). 152–162. 26 indexed citations
12.
Nebie, Ouada, David Devos, Valérie Vingtdeux, et al.. (2019). The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science. 26(1). 89–89. 30 indexed citations
13.
Burnouf, Thierry, Lassina Barro, Ouada Nebie, et al.. (2019). Viral safety of human platelet lysate for cell therapy and regenerative medicine: Moving forward, yes, but without forgetting the past. Transfusion and Apheresis Science. 58(6). 102674–102674. 18 indexed citations
14.
Sung, Tzu‐Cheng, Akon Higuchi, Chi-Sheng Hung, et al.. (2019). The effect of human platelet lysate on the differentiation ability of human adipose-derived stem cells cultured on ECM-coated surfaces. Journal of Materials Chemistry B. 7(45). 7110–7119. 17 indexed citations
15.
Barro, Lassina, Ouada Nebie, Yu‐Wen Wu, et al.. (2019). A double‐virally‐inactivated (Intercept–solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells. Transfusion. 59(6). 2061–2073. 18 indexed citations
16.
Barro, Lassina, et al.. (2018). Blood transfusion in sub‐Saharan Africa: understanding the missing gap and responding to present and future challenges. Vox Sanguinis. 113(8). 726–736. 45 indexed citations
18.
Dahourou, Honorine, Jean‐Baptiste Tapko, Yacouba Nébié, et al.. (2012). Mise en place de l’hémovigilance en Afrique subsaharienne. Transfusion Clinique et Biologique. 19(1). 39–45. 9 indexed citations
19.
D'Agostino, S, et al.. (2002). [Surgery of congenital malformations in developing countries: experience in 13 humanitarian missions during 9 years].. PubMed. 23(2). 117–21. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026